Research Progress on Neuromolecular Imaging of REM Sleep Behavior Disorder

Overview

Journal Front Neurol

Specialty Neurology

Date 2022 Oct 27

PMID 36299269

Authors

Chaofan Geng

HongJu Zhang

Affiliations

Soon will be listed here.

Abstract

Idiopathic rapid eye movement sleep behavior disorder (iRBD) is an important non-motor complication of Parkinson's disease. At the same time, iRBD is considered to be the prodromal stage of α-synucleinopathy. This high risk of conversion suggests that iRBD becomes a nerve It is a window for early research on degenerative diseases and is the best candidate for neuroprotection trials. A wide range of neuroimaging techniques has improved our understanding of iRBD as a prodromal stage of the disease. In addition, neuroimaging of abnormal iRBD is expected to be a potential biomarker for predicting clinical phenotypic transformation. This article reviews the research progress of neuromolecular imaging in patients with iRBD from the perspective of iRBD transforming synucleinopathies.

References

Kogan R, Janzen A, Meles S, Sittig E, Renken R, Gurvits V . Four-Year Follow-up of [ F]Fluorodeoxyglucose Positron Emission Tomography-Based Parkinson's Disease-Related Pattern Expression in 20 Patients with Isolated Rapid Eye Movement Sleep Behavior Disorder Shows Prodromal Progression. Mov Disord. 2020; 36(1):230-235. PMC: 7891341. DOI: 10.1002/mds.28260. View

Kashihara K, Imamura T, Shinya T . Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson's disease. Parkinsonism Relat Disord. 2010; 16(4):252-5. DOI: 10.1016/j.parkreldis.2009.12.010. View

Bauckneht M, Chincarini A, De Carli F, Terzaghi M, Morbelli S, Nobili F . Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: A systematic review and meta-analysis. Sleep Med Rev. 2018; 41:266-274. DOI: 10.1016/j.smrv.2018.04.001. View

Wu P, Yu H, Peng S, Dauvilliers Y, Wang J, Ge J . Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorder. Brain. 2014; 137(Pt 12):3122-8. PMC: 4240297. DOI: 10.1093/brain/awu290. View

Treglia G, Stefanelli A, Cason E, Cocciolillo F, Di Giuda D, Giordano A . Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis. Clin Neurol Neurosurg. 2011; 113(10):823-9. DOI: 10.1016/j.clineuro.2011.09.004. View

Holtbernd F, Gagnon J, Postuma R, Ma Y, Tang C, Feigin A . Abnormal metabolic network activity in REM sleep behavior disorder. Neurology. 2014; 82(7):620-7. PMC: 3963420. DOI: 10.1212/WNL.0000000000000130. View

Meles S, Teune L, de Jong B, Dierckx R, Leenders K . Metabolic Imaging in Parkinson Disease. J Nucl Med. 2016; 58(1):23-28. DOI: 10.2967/jnumed.116.183152. View

Chahine L, Brumm M, Caspell-Garcia C, Oertel W, Mollenhauer B, Amara A . Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder. Ann Clin Transl Neurol. 2020; 8(1):201-212. PMC: 7818144. DOI: 10.1002/acn3.51269. View

Rodriguez C, Jaimchariyatam N, Budur K . Rapid Eye Movement Sleep Behavior Disorder: A Review of the Literature and Update on Current Concepts. Chest. 2017; 152(3):650-662. DOI: 10.1016/j.chest.2017.03.015. View

10.

Hanyu H, Inoue Y, Sakurai H, Kanetaka H, Nakamura M, Miyamoto T . Regional cerebral blood flow changes in patients with idiopathic REM sleep behavior disorder. Eur J Neurol. 2010; 18(5):784-8. DOI: 10.1111/j.1468-1331.2010.03283.x. View

11.

Janzen A, Vadasz D, Booij J, Luster M, Librizzi D, Henrich M . Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder. J Parkinsons Dis. 2022; 12(6):1921-1935. PMC: 9535565. DOI: 10.3233/JPD-223201. View

12.

Heller J, Brcina N, Dogan I, Holtbernd F, Romanzetti S, Schulz J . Brain imaging findings in idiopathic REM sleep behavior disorder (RBD) - A systematic review on potential biomarkers for neurodegeneration. Sleep Med Rev. 2016; 34:23-33. DOI: 10.1016/j.smrv.2016.06.006. View

13.

McMillan P, White S, Franklin A, Greenup J, Leverenz J, Raskind M . Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease. Brain Res. 2010; 1373:240-52. PMC: 3038670. DOI: 10.1016/j.brainres.2010.12.015. View

14.

Kim R, Jun J, Kim H, Jung K, Shin Y, Yang T . Peripheral Blood Inflammatory Cytokines in Idiopathic REM Sleep Behavior Disorder. Mov Disord. 2019; 34(11):1739-1744. DOI: 10.1002/mds.27841. View

15.

Takahashi M, Tada T, Nakamura T, Koyama K, Momose T . Efficacy and Limitations of rCBF-SPECT in the Diagnosis of Alzheimer's Disease With Amyloid-PET. Am J Alzheimers Dis Other Demen. 2019; 34(5):314-321. PMC: 6610554. DOI: 10.1177/1533317519841192. View

16.

Sommerauer M, Fedorova T, Hansen A, Knudsen K, Otto M, Jeppesen J . Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study. Brain. 2017; 141(2):496-504. DOI: 10.1093/brain/awx348. View

17.

De Francesco E, Terzaghi M, Storelli E, Magistrelli L, Comi C, Legnaro M . CD4+ T-cell Transcription Factors in Idiopathic REM Sleep Behavior Disorder and Parkinson's Disease. Mov Disord. 2020; 36(1):225-229. DOI: 10.1002/mds.28137. View

18.

Eskildsen S, Iranzo A, Stokholm M, Staer K, Ostergaard K, Serradell M . Impaired cerebral microcirculation in isolated REM sleep behaviour disorder. Brain. 2021; 144(5):1498-1508. DOI: 10.1093/brain/awab054. View

19.

Iranzo A, Santamaria J, Tolosa E . Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions. Lancet Neurol. 2016; 15(4):405-19. DOI: 10.1016/S1474-4422(16)00057-0. View

20.

Arnaldi D, Chincarini A, De Carli F, Fama F, Girtler N, Brugnolo A . The fate of patients with REM sleep behavior disorder and mild cognitive impairment. Sleep Med. 2020; 79:205-210. DOI: 10.1016/j.sleep.2020.02.011. View